Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Antengene Corporation Limited
  6. News
  7. Press Releases
    6996   KYG039571008

ANTENGENE CORPORATION LIMITED

(6996)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ANTENGENE CORPORATION LIMITED
08/23ANTENGENE : Announces Approval of the Phase II Study of Selinexor for the Treatm..
PR
07/30ANTENGENE : Voluntary announcement approval of nda by the mfds for atg-010 (seli..
PU
07/13ANTENGENE : Submits New Drug Application for Selinexor in Taiwan for the Treatme..
PR
07/05ANTENGENE : Announces Acceptance of IND Application in China for the Phase II Cl..
PR
06/11ANTENGENE : Founder And CEO Of Antengene, Dr. Jay Mei, Talks Innovation In Biote..
AQ
05/14ANTENGENE : Voluntary announcement nmpa approval of ind application for a phase ..
PU
05/13ANTENGENE : Voluntary announcement nmpa approval of ind application for a phase ..
PU
05/12ANTENGENE : Announces IND Approval in China for a Global Phase III Trial of Seli..
PR
05/05ANTENGENE : Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSC..
PR
05/03ANTENGENE : Voluntary announcement building of the drug discovery and manufactur..
PU
04/22ANTENGENE : Form of proxy for the 2020 annual general meeting
PU
04/06ANTENGENE : Voluntary announcement nmpa approval of ind application for atg-019 ..
PU
04/05ANTENGENE : Announces NMPA Approval of IND Application for ATG-019 in Patients w..
PR
03/25ANTENGENE : Announces Financial Results for Full Year 2020
PR
03/25ANTENGENE : Resignation and appointment of non-executive director
PU
03/14ANTENGENE : Included in the Shenzhen-Hong Kong Stock Connect
PR
03/04ANTENGENE : Notice of date of board meeting
PU
02/28ANTENGENE : 6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thema..
PR
02/23ANTENGENE : Announces NDA for ATG-010 (Selinexor) Granted Priority Review by Chi..
PR